$10.950
-0.138 (-1.26%)Al cierre
Comparativa sectorial de INKT
In the context of the broader market, INKT competes directly with industry leaders such as IMA and ELOX. With a market capitalization of $57.51M, it holds a significant position in the sector. When comparing efficiency, INKT's gross margin of N/A stands against IMA's N/A and ELOX's N/A. Such benchmarking helps identify whether Mink Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Mink Therapeutics Inc
The company has been experiencing significant net losses, with Q2 2026 net loss at $3.1 million and a consistent negative EPS trend, with the latest at -0.62. The current ratio is 1.23, indicating some liquidity, but overall financial health appears weak.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.